CeriBell, Inc.

CBLLNASDAQHealthcare● Active

$18.68

+$0.43(+2.34%)

Market Cap$708663396

P/E Ratio—

52W High$24.33

52W Low$10.85

Avg Volume297K

Open$18.36

Beta0.84

Free Cash Flow Financials Revenue

CeriBell, Inc. (CBLL) Free Cash Flow & Analysis

Annual & trailing free cash flow, FCF margin, YoY change, valuation ratios, and peer context.

CBLL · free cash flow · updated Jun 8, 2026

Core FCF metrics

CBLL · FCF · TTM · margin & CAGR

Free cash flow was −$41.6M for FY2025 (fiscal year ending 2025-12-31), down 14.3% year-over-year The FCF margin was -46.7%.

FY2025 Free Cash Flow−$41.6M▼ -14.3% YoY

Trailing 12M (TTM)−$49.6Mtrailing 4 quarters sum

FCF Margin-46.7%−$41.6M ÷ revenue

3-Year CAGRN/AN/A — contains negative FCF

5-Year CAGRN/AN/A — contains negative FCF

FormulaFCF = Operating Cash Flow − Capital ExpendituresTTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /cash-flow-statement · SEC 10-K / 10-Q · USDUpdated: Jun 8, 2026

Annual free cash flow history

FCF ($B, upper) · YoY Growth % (lower)

Positive FCFNegative FCF

Free Cash Flow

YoY Growth %

Annual free cash flow data

CBLL · free cash flow history · annual / quarterly

Fiscal YearOperating CFCapExFree Cash FlowYoY ChangeFCF Margin

FY2025Latest−$40.8M(1M)−$41.6M▼ 14.3%-46.7%

FY2024−$35.0M(1M)−$36.4M▼ 20.7%-55.6%

FY2023−$29.2M(1M)−$30.1M▲ +7.3%-66.7%

FY2022−$32.0M(1M)−$32.5M—-125.5%

FCF = Operating Cash Flow − Capital Expenditures · CapEx shown as (negative) · Source: SEC filings via FMP

FCF valuation metrics

CBLL · P/FCF · FCF yield · FCF per share

CeriBell, Inc. (CBLL) reported negative free cash flow of −$0.04B. FCF-based valuation ratios are not meaningful when FCF is negative.

FCF Yield (TTM)

N/A

Free Cash Flow ÷ Market Cap

per FMP freeCashFlowYieldTTM definition

FCF per Share (TTM)

N/A

TTM FCF ÷ Shares Outstanding

Price / FCF

N/A

Share Price ÷ FCF per Share

EV / FCF (TTM)

N/A

Enterprise Value basis

FCF-based valuation ratios are only meaningful when free cash flow is positive. Negative FCF indicates capital expenditures exceeded operating cash flow.

Source: FMP /key-metrics-ttm · /cash-flow-statement Q · /income-statementFY2025 · 2025-12-31

Cash flow statement summary

CBLL · cash flow statement · operating / investing / financing

For FY2025, CeriBell, Inc. generated −$40.8M in operating cash flow and spent 1M in capital expenditures, yielding −$41.6M in free cash flow.

Operating Activities

−$40.8M

Cash from core business operations

2025-12-31

Investing Activities

−$118.1M

CapEx, acquisitions & investments

2025-12-31

Financing Activities

+$5.1M

Buybacks, dividends & debt

2025-12-31

FCF FormulaOperating CF (−$40.8M) − |CapEx| (1M) = FCF (−$41.6M)

For the complete Operating / Investing / Financing line-item breakdown:

View Full Cash Flow Statement →

Free cash flow vs peers (Healthcare)

CBLL vs peers · FCF

#CompanyFree Cash FlowYoYFCF MarginRelative

CeriBell, Inc.YOU

CBLL

−$41.6M-14.3%-46.7%

Loss

UnitedHealth Group Incorporated

UNH

$16.07B-22.4%3.6%

82%

Eli Lilly and Company

LLY

$8.97B+2065.6%13.8%

46%

Healthcare · Sorted by FCF · FMP /cash-flow-statementFull FCF Rankings →

About Free Cash Flow & Methodology

CeriBell, Inc. (CBLL) reported free cash flow of −$41.6M for FY2025 (fiscal year ending 2025-12-31), down 14.3% year-over-year. The FCF margin was -46.7%.

CeriBell, Inc. has reported negative free cash flow in recent periods, indicating capital expenditures have exceeded operating cash flow. Data available for 4 fiscal years.

Data sourced from FMP /cash-flow-statement · SEC 10-K / 10-Q · USD.

Q&A and summaries align with SEC 10-K/10-Q cash flow disclosures and FMP /cash-flow-statement where noted.

Revenue Financial statements Net income Earnings Forecast Price history Market cap Cash on hand P/E ratio

Frequently asked questions

CBLL free cash flow · 8 questions

CeriBell, Inc. free cash flow was −$41.6M for FY2025, down 14.3% year-over-year. On a trailing twelve-month (TTM) basis, free cash flow stands at −$49.6M.

CBLL free cash flowCBLL FCFCBLL FCF 2025CBLL free cash flow TTM

▸ Source: FMP /cash-flow-statement · US GAAP · CeriBell, Inc. · CeriBell, Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 8, 2026